Allergic Bronchopulmonary Aspergillosis Associated with Aspergilloma.
10.4046/trd.2004.56.3.302
- Author:
Jeon Su RYU
1
;
Jae Joong BAIK
;
Do Kyun KIM
;
Young Jin KIM
;
Woo Seob EOM
;
Jea Hyun CHO
Author Information
1. Department of Internal Medicine, National Medical Center, Korea. typist@hanmail.net
- Publication Type:Case Report
- Keywords:
Allergic bronchopulmonary aspergillosis;
Aspergilloma
- MeSH:
Adult;
Antibodies;
Aspergillosis, Allergic Bronchopulmonary*;
Aspergillus;
Aspergillus fumigatus;
Asthma;
Bronchi;
Bronchiectasis;
Colon;
Diagnosis;
Eosinophilia;
Female;
Fungi;
Humans;
Hypersensitivity;
Immunoglobulin E;
Itraconazole;
Lung;
Prednisone;
Pulmonary Aspergillosis;
Spores;
Sputum
- From:Tuberculosis and Respiratory Diseases
2004;56(3):302-307
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Aspergilloma and Allergic Bronchopulmonary Aspergillosis(ABPA) are different types of the pulmonary aspergillosis spectrum of diseases. ABPA is an inflammatory disease that causes hypersensitivity to Aspergillus spores growing in the bronchi, which is characterized by asthma, recurrent pulmonary infiltrations or mucoid impaction, eosinophilia and central bronchiectasis. Aspergilloma is a simple colonization of fungus within a cavitary lung lesion, but these diseases rarely coexist. A case of ABPA, coexistent with Aspergilloma, was experienced in a 31 year-old female. The diagnosis was confirmed by the immediate cutaneous reactivity to Aspergillus fumigatus, elevated total IgE antibodies, peripheral eosinophilia, bronchiectasis, growth of Aspergillus species in a sputum culture and radiographic infiltration. Treatment, with prednisone and itraconazole, led to improvement of the respiratory symptoms, reduction of the cavitary lesion and in the total serum IgE level.
